What RevMed’s pancreatic cancer drug meant for one patient - Poll - MDSpire

What RevMed’s pancreatic cancer drug meant for one patient

  • By

  • Elaine Chen

  • Adam Feuerstein

  • Allison DeAngelis

  • June 4, 2026

  • 0 min

Share

Original Source(s)

What RevMed’s pancreatic cancer drug meant for one patient

  • by Elaine Chen, Adam Feuerstein, Allison DeAngelis

  • June 4, 2026

Related Content

Intrathecal nivolumab in metastatic solid tumors with leptomeningeal disease: dose escalation part of the multicenter IT-PD1/NOA-26 phase 1 trial

What do cancer patients discuss online regarding CINV management? A social media-based topic modeling study

Incidence and Survival of Gastro-Entero-Pancreatic Neuroendocrine Neoplasms in the Contemporary Era